Upgrade to SI Premium - Free Trial

Allergan (AGN) Says FDA Accepts sBLAs for BOTOX for Pediatric Patients with Upper and Lower Limb Spasticity

March 7, 2019 8:02 AM
Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental biologics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles